Factors associated with adherence to anti-hypertensive treatment in Pakistan

Saman K Hashmi, Maria B Afridi, Kanza Abbas, Rubina A Sajwani, Danish Saleheen, Philippe M Frossard, Mohammad Ishaq, Aisha Ambreen, Usman Ahmad, Saman K Hashmi, Maria B Afridi, Kanza Abbas, Rubina A Sajwani, Danish Saleheen, Philippe M Frossard, Mohammad Ishaq, Aisha Ambreen, Usman Ahmad

Abstract

Objectives: Poor adherence is one of the biggest obstacles in therapeutic control of high blood pressure. The objectives of this study were (i) to measure adherence to antihypertensive therapy in a representative sample of the hypertensive Pakistani population and (ii) to investigate the factors associated with adherence in the studied population.

Methods and results: A cross-sectional study was conducted on a simple random sample of 460 patients at the Aga Khan University Hospital (AKUH) and National Institute of Cardiovascular Diseases, Karachi, from September 2005-May 2006. Adherence was assessed using the Morisky Medication Adherence Scale (MMAS), with scores ranging from 0 (non-adherent) to 4 (adherent). In addition to MMAS, patient self-reports about the number of pills taken over a prescribed period were used to estimate adherence as a percentage. AKU Anxiety and Depression Scale (AKU-ADS) was incorporated to find any association between depression and adherence. At a cut-off value of 80%, 77% of the cases were adherent. Upon univariate analyses, increasing age, better awareness and increasing number of pills prescribed significantly improved adherence, while depression showed no association. Significant associations, upon multivariate analyses, included number of drugs that a patient was taking (P<0.02) and whether he/she was taking medication regularly or only for symptomatic relief (P<0.00001).

Conclusions: Similar to what has been reported worldwide, younger age, poor awareness, and symptomatic treatment adversely affected adherence to antihypertensive medication in our population. In contrast, monotherapy reduced adherence, whereas psychosocial factors such as depression showed no association. These findings may be used to identify the subset of population at risk of low adherence who should be targeted for interventions to achieve better blood pressure control and hence prevent complications.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.
    1. Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2572.
    1. National Health Survey of Pakistan 1990–1994. Karachi, Pakistan: Pakistan Medical Research Council; 1998. p. 50.
    1. Inkster ME, Donnan PT, MacDonald TM, Sullivan FM, Fahey T. Adherence to antihypertensive medication and association with patient and practice factors. J Hum Hypertens. 2006;20:295–297.
    1. Falaschetti E. Blood pressure. In: Sproston K, Primatesta P, editors. Health Survey for England 2003. TSO; London: 2004. pp. pp 181–220.
    1. Mant J, McManus RJ. Does it matter whether patients take their antihypertensive medication as prescribed? The complex relationship between adherence and blood pressure control. J Hum Hypertens. 2006;20:551–553.
    1. World Health Organization. Chapter III Hypertension in Adherence to Long-Term Therapies-Evidence for Action. 2003. p. 27. Available: . Accessed August 2005.
    1. Berenson GS, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med. 1998;338:1650–1656.
    1. Thompson DW, Furlan AJ. Clinical epidemiology of stroke. Neurol Clin. 1996;14:309–315.
    1. Baune BT, Aljeesh YI, Bender R. The impact of non-compliance with the therapeutic regimen on the development of stroke among hypertensive men and women in Gaza, Palestine. Saudi Med J. 2004;25(11):1683–8.
    1. Baune BT, Aljeesh Y, Bender R. Factors of non-compliance with the therapeutic regimen among hypertensive men and women: a case-control study to investigate risk factors of stroke. Eur J Epidemiol. 2005;20(5):411–9.
    1. World Health Organization. Chapter XIII Hypertension in Adherence to Long-Term Therapies-Evidence for Action. 2003. pp. 129–136. Available: Accessed February 2007.
    1. Haynes RB, McDonald HP, Garg AX. Helping patients follow prescribed treatment: clinical applications. JAMA. 2002;288:2880–2883.
    1. Krousel-Wood M, Hyre A, Muntner P, Morisky D. Methods to improve medication adherence in patients with hypertension: current status and future directions. Curr Opin Cardiol. 2005;20:296–300.
    1. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200–209.
    1. Hassan NB, Hasanah CI, Foong K, Naing L, Awang R, et al. Identification of psychosocial factors of noncompliance in hypertensive patients. J Hum Hypertens. 2006;20:23–29.
    1. Osterberg L, Blaschke T. Drug therapy: Adherence to Medication. N Engl J Med. 2005;353:487–97.
    1. Bloom BS. Daily regimen and compliance with treatment. BMJ. 2001;323:647.
    1. Payne KA, Esmond-White S. Observational studies of antihypertensive medication use and compliance: is drug choice a factor in treatment adherence? Curr Hypertens Rep. 2000;2:515–524.
    1. Lennon C, Hughes CM, Johnston GD, McElnay JC. Identification of psychosocial factors which influence patient adherence with antihypertensive medication. Int J Pharm Pract. 2001;9:R8.
    1. Wang PS, Bohn RL, Knight E, Glynn RJ, Mogun H, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med. 2002;17:504–511.
    1. Almas A, Hameed A, Ahmed B, Islam M. Compliance to antihypertensive therapy. JCPSP. 2006;16:23–26.
    1. Youssef RM, Moubarak II. Patterns and determinants of treatment compliance among hypertensive patients. East Mediterr Health J. 2002;8:4–5.
    1. Cheng JWM, Kalis MM, Feifer S. Patient-Reported Adherence to Guidelines of the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Pharmacotherapy. 2001;21(7):828–841.
    1. Ali BS, Reza H, Khan MM, Jehan I. Development of an indigenous screening instrument in Pakistan: the Aga Khan University Anxiety and Depression Scale. J Pak Med Assoc. 1998;48:261–5.
    1. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.
    1. Pratt RJ, Robinson N, Loveday HP, Pellowe CM, Franks PJ, et al. Adherence to Antiretroviral Therapy: Appropriate use of self-reporting in clinical practice, HIV Clin Trials. 2001;2:146–159.
    1. Garfield FB, Caro JJ. Compliance and hypertension. Curr Hypertens Rep. 1999;1:502–506.
    1. Rudd P, Ahmad S, Zachary V, Barton C, Bonduelle D. Antihypertensive drug trials, contributions from medication monitors. In: Cramer JA, Spilker B, editors. Patient Compliance in Medical Practice and Clinical Trials. Raven Press Ltd; New York: 1991. pp. pp 283–299.
    1. Caro JJ, Salas M, Speckman JL, et al. Persistence with treatment for hypertension in actual practice. CMAJ. 1999;160:31–37.
    1. Monane M, Bohn RL, Gurwitz JH, et al. A population-based study of compliance with antihypertensive therapy: role of age, gender and race. Am J Public Health. 1996;86:1805–1809.
    1. Krousel-Wood M, Thomasa S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357–362.
    1. Gryglewska B. How can we improve the effectiveness of treatment in elderly hypertensives? Blood Press. 2005;2:46–9.
    1. Yiannakopoulou ECh, Papadopulos JS, Cokkinos DV, Mountokalakis TD. Adherence to antihypertensive treatment: a critical factor for blood pressure control. Eur J Cardiovasc Prev Rehabil. 2005;12:243–9.
    1. Iskedjian M, Einarson TR, MacKeigan LD, et al. Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clin Ther. 2002;24:302–316.
    1. Baune BT, Aljeesh Y. The association of psychological stress and health related quality of life among patients with stroke and hypertension in Gaza Strip. Ann Gen Psychiatry. 2006;5(1):6.
    1. Wang PS, Bohn RL, Knight E, et al. Non-compliance with antihypertensive medications. J Gen Intern Med. 2002;17:504–511.
    1. Egan BH, Lackland DT, Cutler NE. Awareness, knowledge and attitudes of older Americans about high blood pressure. Arch Intern Med. 2003;163:681–687.
    1. Dunbar-Jacob J, Burke LE, Puczynski S. Clinical assessment and management of adherence to medical regimens. In: Nicassio M, Smith T, editors. Managing Chronic Illness: A Biophysical Perspective. American Psychological Association; Washington, DC: 1995. pp. 313–350.

Source: PubMed

スポンサーと協力者

医学的状態

薬物療法

3
購読する